Search
Displaying 181–190 of 693 for “retinal diseases”
-
FDA Authorizes Clinical Trial for CRISPR/Cas9 Therapy for LCA 10
Research NewsEditas Medicine, a company developing gene-editing treatments, has received authorization from the US Food and Drug Administration to launch a clinical trial for its emerging CRISPR/Cas9 therapy for people with a mutation in the gene CEP290, which causes Leber congenital amaurosis 10 (LCA10). LCA causes severe vision loss or blindness at birth.
-
Disease
X-linked retinoschisis (XLRS) is an inherited retinal disease causing vision loss due to splitting of the layers of the retina.
-
Need-to-Know Information about Clinical Trials
Research NewsA primer on what you can expect from clinical trials.
-
Research News
More good news about treatments and technological advances for restoring vision for people with retinal diseases.
